OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

GNLX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genelux (GNLX) Earnings Date & Reports

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GNLX is expected to report earnings to rise 4.76% to -21 cents per share on August 19

Q2'25

Est.

$-0.22

Q1'25

Beat

by $0.01

Q4'24

Est.

$-0.25

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -21 cents. With 192.78K shares outstanding, the current market capitalization sits at 94.34M.

View a ticker or compare two or three

Compare

GNLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GNLX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2625 Townsgate Road

Phone

+1 805 267-9889

Employees

Web

https://www.genelux.com